AMGN

Nasdaq

AMGEN INC

Latest disclosureAugust 13, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 7 sales

Price by TradingView

Insider transactions 99

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 7 trades on this page.

Sale disclosed

Rachna Khosla

SVP, Business Development

Common Stock

Reported value: $825.13K
Reported price: $412.567 / share

Sale disclosed

Rachna Khosla

SVP, Business Development

Common Stock

Reported value: $521.36K
Reported price: $416.4256 / share

Sale disclosed

Derek Miller

SVP, Human Resources

Common Stock

Reported value: $832.86K
Reported price: $402.5444 / share

Sale disclosed

Derek Miller

SVP, Human Resources

Common Stock

Reported value: $733.03K
Reported price: $402.5444 / share

Sale disclosed

Nancy A. Grygiel

SVP & CCO

Common Stock

Reported value: $792.26K
Reported price: $402.1601 / share

Sale disclosed

Nancy A. Grygiel

SVP & CCO

Common Stock

Reported value: $402.16K
Reported price: $402.1601 / share

Sale disclosed

Nancy A. Grygiel

SVP & CCO

Common Stock

Reported value: $400.45K
Reported price: $323.7272 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
SVP, Business Development	Common StockSale	2,000$412.57 / share	$825.13K	Aug 11Filed Aug 13 · 2d later	SEC filing
SVP, Business Development	Common StockSale	1,252$416.43 / share	$521.36K	Aug 13Filed Aug 13 · 0d later	SEC filing
SVP, Human Resources	Common StockSale2 trades	3,890avg $402.54 / share	$1.57M	Aug 6Filed Aug 7 · 1d later	2 filings 2,069 @ $402.54 · $832.86KSEC filing 1,821 @ $402.54 · $733.03KSEC filing
SVP & CCO	Common StockSale2 trades	2,970avg $402.16 / share	$1.19M	Aug 6Filed Aug 7 · 1d later	2 filings 1,970 @ $402.16 · $792.26KSEC filing 1,000 @ $402.16 · $402.16KSEC filing
SVP & CCO	Common StockSale	1,237$323.73 / share	$400.45K	May 4Filed May 5 · 1d later	SEC filing

Congress transactions 19

All Congress filings

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 22, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 26, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 26, 2026

Partial sale disclosed

Amgen Inc. - Common Stock · Stock

The filing reports a partial sale for a spouse.

Sheldon WhitehouseReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 12, 2026

Full sale disclosedAmended report

Amgen Inc · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 15, 2025

Full sale disclosed

Amgen Inc. - Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

Maria Elvira SalazarReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 17, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Maria Elvira SalazarReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 24, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 29, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 16, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 19, 2024

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 23, 2024

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 3, 2025

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 3, 2025

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Marjorie Taylor Greene official portrait

Marjorie Taylor GreeneReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 24, 2025

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 25, 2025

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Marjorie Taylor GreeneReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 11, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000318154
Latest public acceptance: Aug 13, 2026, 11:05 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

SVP, Business Development

Common StockSale

2,000$412.57 / share

$825.13K

Aug 11Filed Aug 13 · 2d later

SEC filing

SVP, Business Development

Common StockSale

1,252$416.43 / share

$521.36K

Aug 13Filed Aug 13 · 0d later

SEC filing

SVP, Human Resources

Common StockSale2 trades

3,890avg $402.54 / share

$1.57M

Aug 6Filed Aug 7 · 1d later

2 filings

2,069 @ $402.54 · $832.86KSEC filing
1,821 @ $402.54 · $733.03KSEC filing

SVP & CCO

Common StockSale2 trades

2,970avg $402.16 / share

$1.19M

Aug 6Filed Aug 7 · 1d later

2 filings

1,970 @ $402.16 · $792.26KSEC filing
1,000 @ $402.16 · $402.16KSEC filing

SVP & CCO

Common StockSale

1,237$323.73 / share

$400.45K

May 4Filed May 5 · 1d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000318154
Latest public acceptance: Aug 13, 2026, 11:05 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.